Results 231 to 240 of about 232,710 (307)

Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies. [PDF]

Pharmacogenomics J
Khasru MR, Abdul Jalil NA, Nair N, Barton A, Martin P, Ho P, Bluett J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume

Prostate, 2020
The early diagnosis of prostate cancer (PCa) is mainly based on prostate‐specific antigen (PSA) blood levels and digital rectal examination. However, this approach may result in a high rate of negative biopsies and increased detection of clinically ...
Omri Nativ
exaly   +2 more sources

PSA velocity and PSA slope [PDF]

Prostate Cancer and Prostatic Diseases, 2006
The aim of this study is to compare different tools for evaluating prostate-specific antigen (PSA) increase or decrease, such as PSA velocity and PSA slope. This study was conducted on 312 male patients evaluated with transrectal ultrasound-guided biopsy of prostate with six or more cores. Patients with at least three consecutive PSA measurements in at
exaly   +3 more sources

SERUM-PSA, F/T PSA, PSAD, PSA-TZ AND PSA VELOCITY

The Journal of Urology, 1999
The clinical value of prostate-specific antigen (PSA) density in differentiating between prostate cancer and benign prostatic hyperplasia has been the subject of several studies. In this context the question has been raised about the diagnostic benefit of PSA transition-zone density (PSA-TZ density = total PSA/transition-zone volume) in the detection ...
Bob Djavan, Mesut Remzi, Christian Seitz, Michael Marberger, Alex Zlotta, Peter Hammerer   +5 more
openaire   +3 more sources

Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.

New England Journal of Medicine, 2020
Reconsidering Prostate Cancer Mortality Since PSA screening and the treatment that may follow result in trading off one cause of death for another, rather than extending life, providers who support...
H. Welch, Peter C. Albertsen
semanticscholar   +1 more source